Loading…

Autoimmunity in hepatitis C virus carriers: Involvement of ferritin and prolactin

Abstract Background Ferritin and prolactin have been associated with active autoimmune diseases as systemic lupus erythematosus and autoantibody production, but have been little studied in viral infections that present autoimmunity. Objective To investigate the association of these two autoimmune me...

Full description

Saved in:
Bibliographic Details
Published in:Autoimmunity reviews 2011-02, Vol.10 (4), p.210-213
Main Authors: Sousa, Gabriel M, Oliveira, Rodrigo C, Pereira, Mariana M, Paraná, Raymundo, Sousa-Atta, Maria Luiza B, Atta, Ajax M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Ferritin and prolactin have been associated with active autoimmune diseases as systemic lupus erythematosus and autoantibody production, but have been little studied in viral infections that present autoimmunity. Objective To investigate the association of these two autoimmune mediators with the presence of cryoglobulinaemia and non-organ-specific autoantibodies (RF, SMA, β2GPI IgA antibody and ANA) in Brazilian individuals chronically infected with hepatitis C virus (HCV). Methods Ninety-nine patients were evaluated. Ferritin and prolactin levels were determined by chemiluminescent immunoassays. Results Hyperprolactinemia was found in 10 (six men and four women) out of 99 (10.1%) hepatitis C patients. Thirty-eight out of 99 (38.4%) HCV carriers had hyperferritinemia (median level 385 ng/mL). Neither hyperprolactinemia nor hyperferritinemia was associated with cryoglobulinaemia or non-organ-specific autoantibodies ( p > .05). There was an association between hyperprolactinemia and the infection with HCV genotype 3 ( p < .01). Ferritin and ALT levels were correlated ( p < .05). Conclusion Our results suggest that neither prolactin nor ferritin is involved with the extra-hepatic manifestation of autoimmunity observed in HCV carriers.
ISSN:1568-9972
1568-9972
DOI:10.1016/j.autrev.2010.10.003